These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1461390)

  • 21. Anesthesia for elective surgery in patients susceptible to malignant hyperthermia.
    Relton JE
    Int Anesthesiol Clin; 1979; 17(4):141-51. PubMed ID: 521179
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of high dose administration of propofol].
    Nishioka H; Kinuwaki H; Shimoda O; Terasaki H
    Masui; 2000 Oct; 49(10):1142-4. PubMed ID: 11075566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant hyperthermia: clinical aspects and treatment (author's transl)].
    Freitag B
    Zentralbl Chir; 1979; 104(6):353-8. PubMed ID: 452750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hyperthermia susceptibility in patients with osteogenesis imperfecta.
    Peluso A; Cerullo M
    Paediatr Anaesth; 1995; 5(6):398-9. PubMed ID: 8597980
    [No Abstract]   [Full Text] [Related]  

  • 25. [Risk and choice of anesthetics for patients with previous malignant hyperthermia syndrome].
    Bracali AM; Sette MP; Marana E
    Minerva Anestesiol; 1979 Oct; 45(10):749-53. PubMed ID: 553248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of malignant hyperthermia and unusual disease: when you're hot you're hot or maybe not.
    Davis PJ; Brandom BW
    Anesth Analg; 2009 Oct; 109(4):1001-3. PubMed ID: 19762721
    [No Abstract]   [Full Text] [Related]  

  • 27. [Malignant hyperthermia or neuroleptic malignant syndrome?].
    Quevedo-Arechederra MA; Fraile JR; Rodríguez FM; Bermejo L
    Rev Esp Anestesiol Reanim; 1995 Oct; 42(8):349. PubMed ID: 8560059
    [No Abstract]   [Full Text] [Related]  

  • 28. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
    Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
    Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
    [No Abstract]   [Full Text] [Related]  

  • 29. Malignant hyperthermia in China.
    Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
    Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse.
    Valverde A; Boyd CJ; Dyson DH; Pascoe PJ
    J Am Vet Med Assoc; 1990 Oct; 197(8):1051-3. PubMed ID: 2243040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hyperthermia--an overview.
    Dobrovolsky W
    Oral Health; 1979 Jun; 69(6):47-51, 64. PubMed ID: 397453
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
    Gallagher DM; Hyer RL
    J Oral Surg; 1980 Jun; 38(6):438-40. PubMed ID: 6929328
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant hyperthyrodism or malignant hyperthermia?
    Peters KR; Nance P; Wingard DW
    Anesth Analg; 1981 Aug; 60(8):613-5. PubMed ID: 7196176
    [No Abstract]   [Full Text] [Related]  

  • 34. [Propofol in the anesthesia of patients at risk of malignant hyperthermia in pediatric ophthalmic surgery].
    Rolle L; Belluomo-Anello C; Viglietto A; D'Ari G
    Minerva Anestesiol; 1991 Sep; 57(9):602-3. PubMed ID: 1798501
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
    Watson CB; Reierson N; Norfleet EA
    Anesthesiology; 1986 Sep; 65(3):312-4. PubMed ID: 3752576
    [No Abstract]   [Full Text] [Related]  

  • 36. [Isolated postoperative myoglobinuria as the only sign of malignant hyperthermia. Value of spinal anesthesia with bupivacaine in a posterior surgical intervention].
    Pagani I; Ramaioli F; Belforti F; Parrini S; Raimondi M
    Minerva Anestesiol; 1992 Apr; 58(4):213-7. PubMed ID: 1620419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal treatment for malignant hyperthermia today.
    Krivosic-Horber R
    Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):255-9. PubMed ID: 3176862
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant hyperthermia. Recognition, prevention and management.
    Runciman WB
    Dent Anaesth Sedat; 1984 Nov; 13(2):54-8. PubMed ID: 6598445
    [No Abstract]   [Full Text] [Related]  

  • 39. Could this be malignant hyperthermia?
    Choiniere A
    Anesth Analg; 2008 Apr; 106(4):1327-8; author reply 1328-9. PubMed ID: 18349216
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diagnosis of susceptibility to malignant hyperthermia in children].
    Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
    Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.